NCT05147688View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pulmonary DiseaseAsthmaChronic Obstructive Pulmonary Disease
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (1)

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER